Therapeutic vaccines for high-risk HPV-associated diseases

Cancer is the second leading cause of death worldwide, and it is estimated that Human papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV vaccines are extremely effective at preventing infection and neoplastic disease; however, they are prophylactic and do not clear...

Descripción completa

Detalles Bibliográficos
Autores principales: Chabeda, Aleyo, Yanez, Romana J.R., Lamprecht, Renate, Meyers, Ann E., Rybicki, Edward P., Hitzeroth, Inga I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887015/
https://www.ncbi.nlm.nih.gov/pubmed/29277575
http://dx.doi.org/10.1016/j.pvr.2017.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887015/
https://www.ncbi.nlm.nih.gov/pubmed/29277575
http://dx.doi.org/10.1016/j.pvr.2017.12.006

Ejemplares similares